THIRD AMENDMENT TO SECURED PROMISSORY NOTESecured Promissory Note • August 31st, 2021 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledAugust 31st, 2021 Company IndustryThis Third Amendment to Secured Promissory Note (this “Amendment”) is made and entered into as of August 31, 2021 (the “Amendment Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Borrower”), and Ampersand 2018 Limited Partnership, a Delaware limited partnership (the “Noteholder”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Note (as defined below).
THIRD AMENDMENT TO SECURED PROMISSORY NOTESecured Promissory Note • August 31st, 2021 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledAugust 31st, 2021 Company IndustryThis Third Amendment to Secured Promissory Note (this “Amendment”) is made and entered into as of August 31, 2021 (the “Amendment Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Borrower”), and 1315 Capital II, L.P., a Delaware limited partnership (the “Noteholder”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Note (as defined below).